Status:
RECRUITING
Prevalence, Characteristics, Management, and Outcomes of Difficult-to-treat Inflammatory Bowel Disease
Lead Sponsor:
IRCCS Ospedale San Raffaele
Conditions:
Assessment of the Criteria and Risk Factors for DTT-IBD
Eligibility:
All Genders
18-69 years
Brief Summary
Crohn's disease (CD) and ulcerative colitis (UC) are the two main types of chronic inflammatory bowel disease (IBD). Despite recent advances, many patients do not respond to available treatments and o...
Detailed Description
This is a multicentre retrospective cross-sectional study with two aims: 1. To evaluate the prevalence of difficult-to-treat IBD 2. To evaluate which and how demographic and clinical variables affect...
Eligibility Criteria
Inclusion
- Adult patients (age ≥18)
- Diagnosis of IBD: Crohn's disease (CD), ulcerative colitis (UC), or undetermined IBD (IBD-U)
- A least one visit with a gastroenterology specialist after 01/01/2019
Exclusion
- Unconfirmed IBD diagnosis
- Consultation with non-gastroenterology specialists
- Consultation older than January 1st 2019
- Pediatric patients (Age \<18). Pediatric population will be excluded as the DTT-IBD criteria apply to adult patients only.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
972 Patients enrolled
Trial Details
Trial ID
NCT06551194
Start Date
June 1 2024
End Date
December 1 2024
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, Italy, 20132